BSE filing, NSE: GEETANJ. Summary written from the filing by ALFA Finder's alert engine.
Geetanjali Credit and Capital Ltd: key numbers
- Share price
- ₹19.93
- Market cap
- ₹8.81 Cr
- Revenue (annual)
- ₹0.09 Cr
- Net profit (annual)
- ₹0.02 Cr
- P/E (TTM)
- 52.3×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Geetanjali Credit and Capital Ltd
All →Geetanjali Credit and Capital Other Announcement
Geetanjali Credit and Capital Limited submitted the RTA certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30th September 2026.
Geetanjali Credit and Capital Annual General Meeting
Geetanjali Credit and Capital Ltd will hold an Extra-ordinary General Meeting on 06th November 2026 to appoint directors and increase the authorized share capital.
Geetanjali Credit and Capital Capital Structure Change
The Board approved an increase in the Company's authorized share capital from ₹5 Crore to ₹95 Crore. An EGM is scheduled for November 6, 2026, for approval.
Geetanjali Credit and Capital Board Meeting Date
Geetanjali Credit and Capital Limited scheduled a board meeting for October 13, 2026, to consider increasing authorized share capital and convening an Extra-ordinary General Meeting.
Geetanjali Credit and Capital Management Change
Geetanjali Credit and Capital Limited appointed Ms. Ritu Tiwari as an Additional Independent Director and accepted the resignation of Mr. Vishnuji Ravaji Thakor.
Geetanjali Credit and Capital Board Meeting Outcome
Geetanjali Credit and Capital Ltd appointed Mr. Shreedhar Vasant Godbole as Managing Director and CFO, while Mr. Avinash Verma resigned as Additional Executive Director.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.